Chronic Lymphocytic Leukemia CLL Mutations Detection Panel 1 Test
Comprehensive Genetic Analysis for CLL Management
The Chronic Lymphocytic Leukemia CLL Mutations Detection Panel 1 Test represents a cutting-edge molecular diagnostic approach specifically designed for patients diagnosed with chronic lymphocytic leukemia. This comprehensive genetic panel utilizes advanced PCR-MLPA (Multiplex Ligation-dependent Probe Amplification) technology to detect critical chromosomal abnormalities that significantly influence disease progression, treatment response, and overall prognosis in CLL patients.
What This Test Measures and Detects
Our sophisticated CLL Mutations Detection Panel 1 analyzes eight key genetic markers that play crucial roles in CLL pathogenesis and treatment response:
- Chromosome 2p gain – Associated with disease progression and treatment resistance
- 6q deletion – Impacts disease aggressiveness and clinical outcomes
- 8p loss & 8q amplification – Important prognostic indicators for disease monitoring
- 9p21 loss – Critical for understanding disease biology and progression
- 11q deletion – High-risk marker requiring aggressive treatment approaches
- Trisomy 12 – Intermediate risk marker with specific clinical implications
- 13q14 deletion – Favorable prognostic marker when isolated
- 17p deletion – Highest risk marker indicating poor response to conventional therapies
Who Should Consider This Test
This comprehensive genetic panel is essential for patients experiencing:
- Newly diagnosed chronic lymphocytic leukemia requiring risk stratification
- Progressive disease with changing symptoms or treatment response
- Consideration for targeted therapy or clinical trial enrollment
- Family history of hematologic malignancies
- Unexplained lymphocytosis or abnormal blood counts
- Planning for stem cell transplantation or advanced treatment options
Clinical Benefits of CLL Genetic Testing
Undergoing the CLL Mutations Detection Panel 1 provides numerous clinical advantages:
- Personalized Treatment Planning – Results guide selection of targeted therapies and treatment intensity
- Accurate Risk Stratification – Identifies high-risk genetic features requiring aggressive management
- Prognostic Information – Provides valuable insights into disease course and expected outcomes
- Treatment Response Prediction – Helps anticipate response to specific therapeutic agents
- Clinical Trial Eligibility – Essential for enrollment in cutting-edge treatment protocols
- Comprehensive Disease Monitoring – Enables tracking of genetic evolution over time
Understanding Your Test Results
Your CLL Mutations Detection Panel 1 results will provide detailed information about specific genetic abnormalities detected:
- Favorable Prognosis – Isolated 13q14 deletion typically indicates better outcomes
- Intermediate Risk – Trisomy 12 requires careful monitoring and standard treatment approaches
- High-Risk Features – 11q and 17p deletions indicate aggressive disease requiring specialized therapies
- Complex Genetics – Multiple abnormalities may suggest more advanced disease
- Treatment Implications – Specific mutations guide selection of targeted agents like BTK inhibitors
All results should be discussed with your oncologist who will interpret them in the context of your complete clinical picture.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $126 |
| Regular Price | $188 |
Convenient Testing Across the United States
We have diagnostic centers conveniently located in all major US cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our nationwide network ensures accessible, high-quality genetic testing for CLL patients throughout the country.
Take Control of Your CLL Journey
Understanding your genetic profile is crucial for effective CLL management. Our comprehensive CLL Mutations Detection Panel 1 provides the critical information needed to make informed treatment decisions and optimize your care plan. With rapid turnaround times and expert analysis, we deliver reliable results that empower you and your healthcare team.
Ready to schedule your test? Contact our dedicated team today at +1(267) 388-9828 or book your appointment online. Our genetic counselors and oncology specialists are available to answer your questions and guide you through the testing process.
